Key Takeaways
- ORCL shares have surrendered their entire 2025 rally in early 2026, yet the stock trades at an attractive 17.2x forward non-GAAP earnings multiple based on Fiscal 2027 EPS estimates of $8.14.
- Management projects explosive 34% revenue expansion for Fiscal 2027, with total sales expected to surpass the $90 billion threshold.
- Earnings per share growth faces constraints from elevated borrowing costs and substantial dilution from $19.9 billion in fresh equity issuance, capping EPS expansion near 18.5%.
- Mizuho maintains its bullish Outperform stance with a $320 target, highlighting robust execution and rapid cloud infrastructure expansion.
- The consensus view among analysts reflects a Strong Buy recommendation with a mean target price of $251.77, suggesting approximately 79% potential appreciation.
Shares of Oracle have experienced significant turbulence through 2026. Trading near $144.83 as of Tuesday’s session, ORCL has completely retraced the gains accumulated throughout 2025, despite the company’s continued operational momentum.
While the stock price has retreated, Oracle’s fundamental performance paints a compelling picture. The enterprise software giant is projecting Fiscal 2027 revenue exceeding $90 billion, translating to remarkable 34% annual growth. This acceleration would mark the company’s strongest revenue expansion in more than ten years.
Oracle Cloud Infrastructure stands at the center of this growth narrative. OCI delivered exceptional 120% constant-currency growth compared to the prior-year quarter. Artificial intelligence applications are fueling robust demand, with executives noting they’re accelerating capacity deployment timelines in certain regions.
The company recently delivered its Q1 Fiscal 2027 financial report, surpassing expectations on both the top and bottom lines. Non-GAAP earnings per share reached $1.92, representing nearly 30% year-over-year improvement. This performance extends Oracle’s streak to three straight quarters of beating revenue and earnings projections, as noted by Mizuho.
Mizuho maintained its Outperform designation while holding firm on its $320 price objective. The research firm highlighted Oracle’s disciplined approach to operating expenses, with operating margins expanding approximately 35 basis points annually despite facing gross margin headwinds.
Bottom-Line Growth Confronts Significant Obstacles
While topline metrics appear robust, the earnings picture reveals additional complexity. Oracle funded its aggressive expansion through $19.9 billion in new share issuances. This substantial dilution, coupled with an elevated interest rate environment, constrains non-GAAP earnings per share growth to roughly 18.5% for the fiscal year—significantly trailing revenue momentum.
Oracle maintains a considerable debt burden of $125.3 billion, positioning it among the technology sector’s most highly leveraged enterprises. Free cash flow registered negative $5.4 billion during Q1 2027, extending the pattern observed throughout the previous fiscal period. Executives anticipate Fiscal 2027 and 2028 will represent peak capital expenditure years, with the organization transitioning toward self-funded operations thereafter.
Following a single quarter into Fiscal 2027, management already elevated its outlook, projecting net capital expenditures will not exceed $70 billion.
Wall Street Perspectives
Analyst sentiment skews decidedly positive, though viewpoints vary. UBS elevated its price objective to $250. DA Davidson maintained its Buy recommendation with a $225 target. Bernstein preserved its Outperform rating at $325. Conversely, Freedom Broker reduced its target to $205, while Stifel lowered expectations to $200, both expressing concerns regarding margin compression.
InvestingPro research indicates 14 analysts have upwardly revised earnings projections for the forthcoming period. The equity’s PEG ratio stands at 0.51, which InvestingPro identifies as undervalued compared to intrinsic fair value calculations.
The collective Wall Street perspective assigns ORCL a Strong Buy consensus, derived from 25 Buy recommendations and four Hold ratings issued over the past three months. Notably, zero analysts currently assign a Sell rating to the stock.
The consensus price target among Wall Street firms stands at $251.77, implying approximately 79% appreciation potential from present trading levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
